INTRODUCTION
============

Peripherally inserted central catheter (PICC) is the gold standard device for prolonged intravenous therapy and its use is constantly growing. Some of the PICCs benefits are: the ability to maintain prolonged therapy with fewer vein punctures, the low incidence of infection, the possibility to insert this device at bedside, the possibility to administer parenteral nutrition with dextrose concentration greater than 10%, vesicant, irritant, vasoactive drug and solutions with extreme osmolarity or non physiological pH.^[@B1]-[@B3],[@B4],[@B5]-[@B7]^ PICC began to be used in Brazil in the early 1990s, initially in neonatal patients.^[@B5]^ Its use quickly expanded to patients of all ages due to its advantages over other central venous catheters, including reduced risk of pneumothorax and sepsis resulting from colonization of the skin around the insertion point, lower insertion costs compared with other central venous catheters, easy maintenance, and the ability to discharge patients while still continuing antibiotic therapy and chemotherapy.^[@B1],[@B8],[@B9]^ For the PICC to function properly as a central line, it is critical that the tip be properly positioned in the central circulation. When the puncture is performed in the arms, the basilic and the cephalic veins are recommended for insertion. PICC can be inserted via direct puncture, also known as blind puncture or with the aid of ultrasound (US), using the modified Seldinger technique. The tip is positioned using an anatomical measurement which is made before starting the procedure. Improper positioning of the tip in the vascular system is associated with a significant increase in malfunction of the device, fibrin formation, and venous thrombosis. When the tip of the catheter is located in the lower portion of the right atrium or right ventricle, it may cause arrhythmias, tricuspid valve dysfunction, erosion, or atrial thrombosis. The tip of the catheter may also be inadvertently placed in the subclavian vein, jugular vein, or other thoracic veins. This type of poor positioning is consistently associated with pain during infusion, device malfunction, or venous thrombosis.^[@B10],[@B11]^ To confirm the position of the catheter tip, a chest x-ray is required at the end of the procedure. ([Figures 1](#f01){ref-type="fig"} and [2](#f02){ref-type="fig"}) Variations in image interpretation may occur due to anatomic abnormalities or in obese patients. Other forms of verifying the placement of the catheter tip using fluoroscopy and electrocardiogram (ECG) are being incorporated into the procedure to assure correct positioning.^[@B10],[@B12],[@B13]^ The objective of this study is to evaluate whether PICC is safe and suitable for medium- and long-term intravenous therapy in orthopedic patients.

Figure 1Chest x-ray showing the tip of the PICC positioned in the subclavian vein.

Figure 2Chest x-ray showing the tip of the PICC positioned in the superior vena cava.

MATERIALS AND METHODS
=====================

This retrospective cross-sectional study was conducted at the Institute of Orthopedics and Traumatology of the Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (IOT HC FMUSP), approved by the institutional review board (process 13542). We examined the medical records of patients who were treated with PICCs between 2007 to 2017. Of the 1057 medical records pertaining to patients whose treatment included PICC, 34 were excluded for not having complete data for subsequent analysis. A total of 1023 patient records were included. All PICCs were inserted by certified nurses trained in insertion of this catheter. All patients agreed to receive intravenous therapy via PICC and signed an informed consent form. The Intravenous Therapy Group at our institute developed an algorithm which uses the time of intravenous therapy and the characteristics of the drugs prescribed as criteria for selecting central devices. ([Figure 3](#f03){ref-type="fig"}) The following data were obtained from the medical records: age, sex, diagnosis, date of PICC insertion, indication for insertion, type of puncture performed, vein punctured, number of punctures performed, positioning of catheter tip, medications administered, complications related to the use of the catheter, reason for removing the catheter, date of PICC removal, and PICC duration. All catheters used were made of silicone, 4 Fr, and had a single lumen and anti reflux valve. PICCs were inserted via direct puncture or guided by US. PICCs were installed at the patient's bedside, using the maximal barrier technique to establish a sterile field. For safety purposes, the procedures were performed by two nurses, which is the normal practice in our institution. Children under 13 years were sedated in the surgical center in order to perform the procedure. The basilic, cephalic or the veins of the antecubital fossa were punctured. The anatomic measurements were made before starting the procedure. In accordance with the manufacturer's instructions, the nurse measured the distance from the puncture site to the anterior axillary fold, from the anterior axillary fold to the head of the right clavicle, and from the head of the right clavicle to the right edge of the sternum in the third intercostal space. Even if the puncture is made in the left arm, the distance to the head of the right clavicle should still be measured. ([Figure 4](#f04){ref-type="fig"}) After the procedure, all patients underwent chest x-rays to confirm the placement of the catheter tip. The catheter was considered properly positioned when the tip of the PICC was located in the superior vena cava, and poorly positioned when the tip of the catheter was in the peripheral veins or the subclavian vein. Catheters positioned in the atrium or in the jugular vein were repositioned, and an additional chest x-ray was taken. Only the final positioning was considered. The quantitative characteristics were described using summary measures (mean, standard deviation, median, minimum and maximum) and the qualitative characteristics were described using absolute and relative frequencies.^[@B14]^ The data were analyzed with SPSS for Windows version 20.0 software, and Microsoft Excel 2008 was used to tabulate the data.

Figure 3Algorithm for intravenous device selection.

Figure 4Measurements taken prior to procedure for proper positioning of the PICC

RESULTS
=======

The study population (n=1023) was 75.5% men (n=772) and 24.5% women (n=251). The median age was 42.4 ± 18.3 years. The most frequent diagnoses of patients who received PICCs were: postoperative infection of the lower limbs (39%), postoperative infection of the upper limbs (14%), open fractures (12%), and multiple trauma (89%). ([Table 1](#t1){ref-type="table"}) As for veins punctured, 51.6% of the PICCs were inserted in the basilic vein, 38.3% in the cephalic vein, and 10.10% in the veins of the antecubital fossa. In terms of insertion technique, 82.7% of PICCs were inserted via direct puncture and 17.3% were guided by ultrasound. We observed that 70.4% of the catheters were properly positioned, while 29.6% of PICCs were improperly positioned. PICC was properly inserted after the first puncture in 89.7% of cases, the second puncture in 5.7% of cases, the third in 2.6% of cases, the fourth in 1.3% of cases, the fifth in 0.4% of cases, and the sixth in 0.3% of cases. The main indication was antibiotic therapy. The most commonly used antibiotics in treating patients who used PICC were teicoplanin, prescribed in 47.8% of cases (487 patients), followed by amikacin, prescribed in 26.2% of cases (267 patients), clindamycin in 22.5% of cases (229 patients), and gentamicin in 17.8% of cases (181 patients). ([Table 2](#t2){ref-type="table"}) As for the number of antibiotics prescribed to the same patient, 671 patients (65.85%) were treated with two antibiotics, 44 patients (4.32%) used three antibiotics, 11 patients (1.08%) used four antibiotics, and one patient (0.1%) used nine different antibiotics. The patients maintained PICCs for a mean time of 34.3 days; the maximum duration was 414 days. The reasons for PICC removal were: completion of treatment (77.3%), catheter malfunction (5.7%), medical indication (4.6%), accidental removal (2.4%), death (1%), phlebitis (0.7%), removed during surgery to approach the limb (0.6%), and allergic reaction (0.4%). Discharge with PICC (7.3%) is not a reason for withdrawal, but is presented to differentiate patients who completed intravenous therapy in our institute from those who completed therapy in other health services. ([Table 3](#t3){ref-type="table"})

Table 1Distribution of patients receiving PICC, by diagnosis.Diagnosisn%Postoperative infection (upper limbs)40339Postoperative infection (lower limbs)14014Open fracture12012Multiple trauma889Clinical complications747Chronic osteomyelitis677Postoperative infection (pelvic ring)454Pyoarthritis343Postoperative infection (spine)212Tumor141Amputation111Spondylodiscitis61

Table 2Antibiotics most frequently used and infused via PICC.ATB, n (%)n(%)Teicoplanina48747.8%Amicacina26726.2%Clindamicina22922.5%Gentamicina18117.8%Ceftriaxona949.2%Ciprofloxacina858.3%Ceftazidima757.4%Oxacilina696.8%Meropenem434.2%Vancomicina424.1%Colistina393.8%Ertapenem323.1%Ampicilina282.7%Tigeciclina232.3%Cefazolina191.9%Sulbactam131.3%Linezolida121.2%Fluconazol121.2%Imipenem121.2%Metronidazol111.1%Levofloxacina101.0%Piperacilina90.9%Cefepime90.9%Tazobactam80.8%Penicilina20.2%Daptomicina20.2%Sulfametoxazol10.1%Azitromicina10.1%Voriconazol10.1%Claritromicina10.1%Trimetropim10.1%Amoxicilina10.1%[^4]

Table 3Distribution of patients receiving PICC according to reason for catheter removal.Reason for removal, n (%)n%Completion of treatment79177.3Discharged with the catheter757.3Occlusion585.7Medical indication474.6Accidental removal252.4Death101Phlebitis70.7Removed during surgery60.6Allergic reaction40.4

DISCUSSION
==========

Most of the studies describes the uses of PICCs in pediatric patients, cancer patients, or patients in intensive care units.^[@B15]-[@B19]^ Few studies for exclusively orthopedic patients are found in literature, as this series of 1023 cases does. This fact grants this study importance for addressing the use of PICCs in a different group of patients. Valbousquet Schneider et al.^[@B16]^ conducted a retrospective study with 136 orthopedic patients in a military hospital in France from 2009 to 2014. A total of 180 PICCs were inserted using ultrasound-guided puncture. The average duration of the catheter was 21 days. The most frequent diagnosis was osteomyelitis. Sixty-four percent of patients had the catheter removed at the end of the treatment. In 2015, Park et al.^[@B17]^ analyzed 4,101 PICCs inserted by direct puncture in a tertiary hospital in Korea from 2002 to 2010. These authors reported that 33.6% of the patients were attended by the oncology department, 13.3% by internal medicine, 9.8% by general surgery, and 8% by orthopedic surgeons. As for indication, 5% of the catheters were placed for antibiotic therapy, 3.2% for chemotherapy, 2.9% for parenteral nutrition, and 88% for venous access. The basilic vein was punctured in 65.9% of cases, followed by the cephalic vein in 30.9%, and the median antecubital fossa in 3.2% of cases. The catheter remained in place until the end of the treatment in 61.5% of the patients, and was removed in 23.8% of cases because of complications. In this study, 1023 PICCs were inserted between 2007 and 2017. Seventy-five per cent of patients were male and the mean age was 42.4 years (SD: 18.3). Direct puncture (82.7%) and ultrasound-guided puncture (17.3%) were used to insert the PICCs. The average time patients retained the catheter was 34.3 days. The most frequent diagnosis was postoperative infection of the lower limbs. The most frequently punctured vein was the basilica, in 51.6% of the cases. Seventy-seven per cent of hospitalized patients remained until the end of their treatment with the catheter, and 7.3% of the patients were discharged with the catheter to complete treatment on an outpatient basis. A study by Sainathan et al.^[@B20]^ showed that of the 700 PICCs inserted, 48.7% were indicated for prolonged antibiotic treatment, 22.3% for difficult peripheral venous access, and the rest divided between patients in the intensive care unit, infusion of irritating medications, and outpatient treatment. In the present study, 92.8% of PICCs were inserted for antibiotic therapy and 7.2% were inserted to treat clinical complications. The most frequent diagnoses were postoperative infection of the lower limbs (39.4%), followed by postoperative infection of the upper limbs (13.7%), open fractures (11.7%), and multiple trauma (8.6%). The most commonly used antibiotics were teicoplanin (47.8%), amikacin (26.2%), clindamycin (22.5%), and gentamicin (17.8%). We also reported that 71.34% of patients received more than one antibiotic. Teicoplanin has a pH similar to blood (7.35--7.45), while the others are more acidic, and when acidic drugs are infused into the peripheral veins they cause histological changes in the vessel walls; consequently, chemical phlebitis may be a complication.^[@B21]^ For this reason, it is essential to understand the characteristics of the prescribed drugs. In a 2007 study, Trerotola et al.^[@B22]^ analyzed the positioning of PICC tips placed at the patient bedside. The X-rays were interpreted by radiologists who used the angle of the right cephalic trunk as a reference for the origin of the superior vena cava and the rounded portion of the upper part of the right atrium junction to estimate the cavo-atrial junction. Of the 1,654 catheters inserted, 163 (10%) were poorly positioned. The statistical analysis showed that the vein punctured was related to poor placement, with the cephalic vein (16%) presenting the greatest association. Venkatesan et al.^[@B23]^ used the carina as a reference to evaluate the placement of the PICC tip. The catheter was considered properly positioned when the tip was 3--5 cm below the carina. In this study, of the 215 PICCs analyzed, only 37% were properly positioned. In this study, the lower portion of the superior vena cava or the cavo-atrial junction were used as references for as ideal positioning, in accordance with the recommendations of the Infusion Nurse Society (INS) and the National Association of Vascular Access Networks (NAVAN).^[@B24]^ The anatomical reference was the third posterior intercostal space, located via an anteroposterior chest x-ray. Of the 1023 catheters inserted, 70.4% were adequately placed and 29.6% were incorrectly positioned. This study only considered the final positioning of the catheter tip after any repositioning maneuvers (when necessary). As for infection, Liscynesky et al.^[@B25]^ reported that 5% of PICCs were removed because of this complication. These authors also reported that 4% of PICCs were unnecessarily removed because of suspected infection, confirmed by negative blood cultures. In 2013, Chopra et al.^[@B26]^ published a systematic review of 1185 studies to compare the rate of infection of PICC versus central venous catheters (CVC). Of the 1185 studies, 23 met the inclusion criteria. Of the 23 included publications, 20 reported infection as a complication in PICC and CVC. The authors concluded that the rate of infection in patients who used PICC for intravenous therapy was lower than in patients who utilized CVC. In this study, 5.7% of the catheters were removed by medical recommendation because of suspected infection. After samples from all the removed catheter tips and the patient's peripheral blood were cultured, no cases of catheter-related infection were confirmed. The low rate of complications found in this study may be associated with less severe clinical condition of orthopedic patients and the choice of a smaller caliber PICC with a single lumen (4 Fr). Finally, this is the first study in our region that reports the use of PICC exclusively in orthopedic patients, and is also one of the few in literature that evaluates the benefits and complications of this catheter in this group of patients. The low rate of complications reported, especially for thrombosis and infection (which generate great concern related to the use of this catheter and were not observed in this study) differentiate this study from other publications.

CONCLUSION
==========

The peripherally inserted central catheter is an intravenous device which is safe and suitable for medium- and long-term intravenous therapy in hospitalized or discharged orthopedic patients.
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